388 related articles for article (PubMed ID: 23067181)
21. Management of acquired haemophilia A.
Collins PW
J Thromb Haemost; 2011 Jul; 9 Suppl 1():226-35. PubMed ID: 21781259
[TBL] [Abstract][Full Text] [Related]
22. Inhibitors in young boys with haemophilia.
Lusher JM
Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):457-68. PubMed ID: 11030045
[TBL] [Abstract][Full Text] [Related]
23. [Long-term remission after i.v. immunoglobulin therapy in acquired antihemophilic factor hemophilia with systemic lupus erythematosus].
Pirner K; Rösler W; Kalden JR; Manger B
Z Rheumatol; 1990; 49(6):378-81. PubMed ID: 2128157
[TBL] [Abstract][Full Text] [Related]
24. Acquired factor VIII inhibitors.
Franchini M; Lippi G
Blood; 2008 Jul; 112(2):250-5. PubMed ID: 18463353
[TBL] [Abstract][Full Text] [Related]
25. [Anti-factor VIII antibodies in children with hemophilia, and the management of hemorrhage].
Klukowska A; Adamowicz-Salach A; Kamińska D; Zieleniewska B
Pol Tyg Lek; 1987 Jul; 42(30):911-4. PubMed ID: 3118341
[No Abstract] [Full Text] [Related]
26. Transplacental transfer of postpartum inhibitors to factor VIII.
Lulla RR; Allen GA; Zakarija A; Green D
Haemophilia; 2010 Jan; 16(1):14-7. PubMed ID: 19500168
[TBL] [Abstract][Full Text] [Related]
27. Immune tolerance therapy in patients with acquired hemophilia.
von Depka M
Hematology; 2004 Aug; 9(4):245-57. PubMed ID: 15621732
[TBL] [Abstract][Full Text] [Related]
28. Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors Organisation.
Hay CR; Ludlam CA; Colvin BT; Hill FG; Preston FE; Wasseem N; Bagnall R; Peake IR; Berntorp E; Mauser Bunschoten EP; Fijnvandraat K; Kasper CK; White G; Santagostino E
Thromb Haemost; 1998 Apr; 79(4):762-6. PubMed ID: 9569189
[TBL] [Abstract][Full Text] [Related]
29. Acquired hemophilia A: a review of recent data and new therapeutic options.
Franchini M; Vaglio S; Marano G; Mengoli C; Gentili S; Pupella S; Liumbruno GM
Hematology; 2017 Oct; 22(9):514-520. PubMed ID: 28441921
[TBL] [Abstract][Full Text] [Related]
30. The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A double-blind clinical trial.
Sjamsoedin LJ; Heijnen L; Mauser-Bunschoten EP; van Geijlswijk JL; van Houwelingen H; van Asten P; Sixma JJ
N Engl J Med; 1981 Sep; 305(13):717-21. PubMed ID: 6790990
[TBL] [Abstract][Full Text] [Related]
31. Acquired Hemophilia A: A Case Report.
Shen M; Wang S; Sessa J; Hanna A; Axelrad A; Ali F
J Pharm Pract; 2020 Aug; 33(4):562-566. PubMed ID: 30727803
[TBL] [Abstract][Full Text] [Related]
32. [Acquired factor VIII deficiency treated with cyclosporine].
Leinøe EB; Jørgensen M; Nielsen JD
Ugeskr Laeger; 1999 Aug; 161(34):4762-3. PubMed ID: 10500467
[TBL] [Abstract][Full Text] [Related]
33. [Acquired hemophilia caused by autoantibodies against factor VIII coagulation activity. Clinical, biological study and therapeutic indications. Experience based on a study of 9 cases].
Liozon E; Delaire L; Turlure P; Jaccard A; Loustaud-Ratti V; Réméniéras L; Julia A; Gaillard S; Bordessoule D; Vidal E
Ann Med Interne (Paris); 1997; 148(7):477-90. PubMed ID: 9538386
[TBL] [Abstract][Full Text] [Related]
34. Treatment of minor severe acquired haemophilia. Is there a rationale for immunoadsorption?
Goldmann G; Marquardt N; Horneff S; Oldenburg J; Zeitler H
Atheroscler Suppl; 2015 May; 18():74-9. PubMed ID: 25936308
[TBL] [Abstract][Full Text] [Related]
35. [Recombinant activated Factor VII (Novoseven Novo Nordisk) for hemostasis in acquired Factor VIII-inhibitor hemophilia].
Meili EO; Dazzi H; von Felten A
Schweiz Med Wochenschr; 1995 Mar; 125(9):405-11. PubMed ID: 7892567
[TBL] [Abstract][Full Text] [Related]
36. Twelve years of experience of acquired hemophilia A: trials and tribulations in South Australia.
Tay L; Duncan E; Singhal D; Al-Qunfoidi R; Coghlan D; Jaksic W; Szabo F; McRae S; Lloyd J
Semin Thromb Hemost; 2009 Nov; 35(8):769-77. PubMed ID: 20169513
[TBL] [Abstract][Full Text] [Related]
37. [A rare disease but with a very high hemorrhagic risk: acquired hemophilia A].
Delisle V; Ternisien C; Beurrier P; Zandecki M
Ann Biol Clin (Paris); 2000; 58(6):741-4. PubMed ID: 11098173
[No Abstract] [Full Text] [Related]
38. Acquired hemophilia A.
Franchini M
Hematology; 2006 Apr; 11(2):119-25. PubMed ID: 16753853
[TBL] [Abstract][Full Text] [Related]
39. Idiopathic factor VIII inhibitor autoantibody in a man presented after accident.
Mansouritorghabeh H; Lak M; van Heerde WL
Clin Appl Thromb Hemost; 2009 Oct; 15(5):588-90. PubMed ID: 18550586
[TBL] [Abstract][Full Text] [Related]
40. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
Mahasandana C; Patharathienskul D; Suvatte V
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
